4 ms·
Peter Thiel is behind this, which is both good and bad. https://qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly/ https://
by mikestaub 7y ago
Peter Thiel is behind this, which is both good and bad. https://qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly/ https://qz.com/1454785/a-millionaire-couple-is-threatening-t...
- Craighead 7y agoBillionaire Fascist Vampire Peter Thiel?
- apqwer 7y agoI think it is good, he is a libertarian and providing freedom of choice is an ideal he would try to push for.
- stjohnswarts 7y agoHe has a poor record as a libertarian when it conflicts with his personal interests
- found_the_vegan 7y agoNot according to that article. Sounds like he is using a charity to backdoor fund his own private investments in to the research. > “From generations of practitioners and researchers before us, we have received knowledge about these substances, their risks, and ways to use them constructively,” reads the statement. “In turn, we accept the call to use that knowledge for the common good and to share freely whatever related knowledge we may discover or develop.” > It has been signed by 104 individual scientists, scholars, and practitioners, 21 research and service organizations, including MAPS, Heffter, Usona, and 12 psychedelic societies and integration circles. Compass has not signed. Given Thiel's track record I think it's not very likely he is doing this for a "freedom of choice" but more as "Opportunity to get richer".
- anythingnonidin 7y agoNot true. Thiel backed COMPASS Pathways which got breakthrough status last year. The Usona Institute, which just got breakthrough status this month, also for a use of psilocybin, is to my knowledge not supported by Thiel. > Back in late 2018, the FDA granted Breakthrough Therapy status to the ongoing work from COMPASS Pathways investigating psilocybin, the key psychoactive compound in magic mushrooms, as a therapy for treatment-resistant depression. A large, multi-center Phase 2 trial spanning the US, UK and Europe is currently underway testing a variety of dosing strategies. > This new FDA Breakthrough Therapy approval focuses on a seven-site, Phase 2 trial currently underway in the United States. Coordinated by a non-profit research organization called the Usona Institute, the trial is exploring the antidepressant properties of a single psilocybin dose in treating patients with major depressive disorder.
- stjohnswarts 7y agoThiel is just a human being, just because he's proven to be a jerk in the past doesn't mean he can't do good in other areas. Just like the slave owning people who drafted the Declaration of Independence and Bill of Rights.